Your browser doesn't support javascript.
loading
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Temesgen, Zelalem; Burger, Charles D; Baker, Jason; Polk, Christopher; Libertin, Claudia R; Kelley, Colleen F; Marconi, Vincent C; Orenstein, Robert; Catterson, Victoria M; Aronstein, William S; Durrant, Cameron; Chappell, Dale; Ahmed, Omar; Chappell, Gabrielle; Badley, Andrew D.
Afiliação
  • Temesgen Z; Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: temesgen.zelalem@mayo.edu.
  • Burger CD; Mayo Clinic, Division of Pulmonary, Allergy and Sleep Medicine, Jacksonville, FL, USA.
  • Baker J; Hennepin Healthcare Research Institute, Minneapolis, MN, USA.
  • Polk C; Atrium Health, Charlotte, NC, USA.
  • Libertin CR; Mayo Clinic, Division of Infectious Diseases, Jacksonville, FL, USA.
  • Kelley CF; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA; Grady Memorial Hospital, Atlanta, GA, USA.
  • Marconi VC; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA; Rollins School of Public Health and Emory Vaccine Center, Atlanta, GA, USA.
  • Orenstein R; Mayo Clinic Arizona, Division of Infectious Diseases, Phoenix, AZ, USA.
  • Catterson VM; BioSymetrics, New York, NY, USA.
  • Aronstein WS; CTI, Clinical Trial Services, Covington, KY, USA.
  • Durrant C; Humanigen, Burlingame, CA, USA.
  • Chappell D; Humanigen, Burlingame, CA, USA.
  • Ahmed O; Humanigen, Burlingame, CA, USA.
  • Chappell G; Humanigen, Burlingame, CA, USA.
  • Badley AD; Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Lancet Respir Med ; 10(3): 237-246, 2022 03.
Article em En | MEDLINE | ID: mdl-34863332
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2022 Tipo de documento: Article